Loading…

Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial

Chronic kidney disease with metabolic acidosis is common in older people, but the effectiveness of oral sodium bicarbonate therapy in this group is unclear. We tested whether oral sodium bicarbonate provides net health benefit for older people with advanced chronic kidney disease and serum bicarbona...

Full description

Saved in:
Bibliographic Details
Published in:BMC medicine 2020-04, Vol.18 (1), p.91-91, Article 91
Main Authors: Duncan, Neill, Sumukadas, Deepa, Avenell, Alison, Rauchhaus, Petra, Mishra, Biswa, Stevens, Paul E, Warwick, Graham, Balasubramaniam, Gowrie, Hampson, Geeta, Band, Margaret, Lambie, Stewart, Witham, Miles D, Chong, Huey Yi, Wilkie, Martin, Tse, Wai, Ahmed, Aimun, McNamee, Paul, Lamb, Edmund J, Plews, Deirdre, Kirk, Adam, Bhatnagar, Deepak, Winnett, Georgia, Kennedy, Gwen, Mitra, Sandip, Donnan, Peter T, Kalra, Philip A, Soiza, Roy L, Chan, Anthony, Littleford, Roberta, Basnayake, Kolitha, Hu, May Khei, Nicholas, Johann, Almond, Michael K
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic kidney disease with metabolic acidosis is common in older people, but the effectiveness of oral sodium bicarbonate therapy in this group is unclear. We tested whether oral sodium bicarbonate provides net health benefit for older people with advanced chronic kidney disease and serum bicarbonate concentrations
ISSN:1741-7015
1741-7015
DOI:10.1186/s12916-020-01542-9